Cite
HARVARD Citation
Shi, Y. et al. (n.d.). 3216 Gemcitabine-based regimens without high-dose therapy consolidation generated prolonged disease control in refractory or relapsed Hodgkin lymphoma: a single institutional experience. European journal of cancer. pp. S654-. [Online].